202 related articles for article (PubMed ID: 31002491)
1. Small Molecule Potentiation of Gram-Positive Selective Antibiotics against
Martin SE; Melander RJ; Brackett CM; Scott AJ; Chandler CE; Nguyen CM; Minrovic BM; Harrill SE; Ernst RK; Manoil C; Melander C
ACS Infect Dis; 2019 Jul; 5(7):1223-1230. PubMed ID: 31002491
[TBL] [Abstract][Full Text] [Related]
2. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
3. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.
Minrovic BM; Jung D; Melander RJ; Melander C
ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069
[TBL] [Abstract][Full Text] [Related]
4. The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo.
Cebrián R; Xu C; Xia Y; Wu W; Kuipers OP
Int J Antimicrob Agents; 2021 Nov; 58(5):106434. PubMed ID: 34525402
[TBL] [Abstract][Full Text] [Related]
5. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
[TBL] [Abstract][Full Text] [Related]
6. Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii.
Marrujo SA; Hubble VB; Yang J; Wang M; Nemeth AM; Barlock SL; Juarez D; Smith RD; Melander RJ; Ernst RK; Chang M; Melander C
Eur J Med Chem; 2023 May; 253():115329. PubMed ID: 37023677
[TBL] [Abstract][Full Text] [Related]
7. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
[TBL] [Abstract][Full Text] [Related]
8. Colistin-glycopeptide combinations against multidrug-resistant
Sanderink D; Cassisa V; Chenouard R; Mahieu R; Kempf M; Dubée V; Eveillard M
Future Microbiol; 2019 May; 14():581-586. PubMed ID: 31172805
[No Abstract] [Full Text] [Related]
9. Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.
Arivett BA; Fiester SE; Ohneck EJ; Penwell WF; Kaufman CM; Relich RF; Actis LA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7657-65. PubMed ID: 26416873
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
Shin B; Park W
J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
[TBL] [Abstract][Full Text] [Related]
11. SPR741, an Antibiotic Adjuvant, Potentiates the
Zurawski DV; Reinhart AA; Alamneh YA; Pucci MJ; Si Y; Abu-Taleb R; Shearer JP; Demons ST; Tyner SD; Lister T
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947471
[No Abstract] [Full Text] [Related]
12. In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant
Jangra M; Raka V; Nandanwar H
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708842
[TBL] [Abstract][Full Text] [Related]
13. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
14. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
15. New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.
Smani Y; Pachón-Ibáñez ME; Pachón J
Expert Opin Pharmacother; 2016 Jun; 17(9):1207-14. PubMed ID: 27067283
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
Mataracı Kara E; Yılmaz M; Özbek Çelik B
J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
[TBL] [Abstract][Full Text] [Related]
17. Acinetobacter baumannii OxPhos inhibitors as selective anti-infective agents.
Rubin H; Selwood T; Yano T; Weaver DG; Loughran HM; Costanzo MJ; Scott RW; Wrobel JE; Freeman KB; Reitz AB
Bioorg Med Chem Lett; 2015 Jan; 25(2):378-83. PubMed ID: 25496770
[TBL] [Abstract][Full Text] [Related]
18. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Khalil MAF; Moawad SS; Hefzy EM
J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
[TBL] [Abstract][Full Text] [Related]
19. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections.
Cruz-Muñiz MY; López-Jacome LE; Hernández-Durán M; Franco-Cendejas R; Licona-Limón P; Ramos-Balderas JL; Martinéz-Vázquez M; Belmont-Díaz JA; Wood TK; García-Contreras R
Int J Antimicrob Agents; 2017 Jan; 49(1):88-92. PubMed ID: 27939675
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
